Introduction
Ciclesonide is a corticosteroid used in the form of a nasal spray to treat allergic rhinitis. It helps reduce inflammation and alleviate symptoms such as nasal congestion, sneezing, and runny nose.
Uses
Ciclesonide nasal spray is used to manage and prevent symptoms of allergic rhinitis in adults and children aged 6 years and older. It is effective in reducing nasal inflammation and controlling symptoms like nasal congestion, sneezing, and nasal itching.
Mechanism of Action
Ciclesonide is a prodrug that is converted into its active form, des-ciclesonide, once it reaches the nasal mucosa. It works by binding to glucocorticoid receptors in the nasal tissues, leading to a reduction in inflammation and suppression of the immune response.
How Long Does It Take to Work?
Relief of nasal symptoms with Ciclesonide nasal spray typically begins within 1-2 days of starting treatment, with the full effect being observed in 1-2 weeks. It is important to use it regularly for optimal results.
Absorption
Ciclesonide is administered topically via nasal spray, resulting in minimal systemic absorption. The majority of the drug remains localized in the nasal mucosa.
Route of Elimination
The active metabolite, des-ciclesonide, is primarily metabolized in the liver and excreted in the urine. The systemic clearance is relatively low due to the minimal systemic absorption of Ciclesonide.
Dosage
1 spray (50 micrograms/spray) in each nostril once a day. The maximum total daily dosage should not exceed 2 sprays in each nostril (200 micrograms/day).Priming information: Gently shake the bottle and prime Ciclesonide nasal spray by actuating eight times before using for the first time or when not used for 4 consecutive days.
For adults and children aged 12 years and older, the recommended dosage is 1 spray (approximately 50 mcg) in each nostril once daily. For children aged 6 to 11 years, the usual dose is 1 spray (50 mcg) in each nostril once daily. The maximum recommended dose should not exceed 2 sprays in each nostril once daily.
Administration
Ciclesonide nasal spray should be administered intranasally. The spray should be directed away from the nasal septum and aimed towards the side wall of the nostril. The bottle should be shaken gently before each use, and the user should blow their nose before administration.
Side Effects
Common side effects include nasal irritation, bleeding, and dryness. Some users may experience a bitter taste or headache. Rarely, more serious effects like nasal septum perforation or allergic reactions may occur.
Toxicity
Overuse or incorrect administration can lead to systemic corticosteroid effects, including adrenal suppression. Symptoms of overdose may include Cushing's syndrome, characterized by weight gain, hypertension, and glucose intolerance.
Precautions
Precautions should be taken in patients with a history of nasal surgery, nasal ulcers, or infections. It should be used with caution in patients with active tuberculosis or other infections. Regular monitoring is advised for patients with chronic use.
Interaction
Drug interactions are minimal due to the localized effect of Ciclesonide. However, caution is advised when using it in combination with other nasal medications or corticosteroids.
Disease Interaction
Ciclesonide should be used with caution in patients with a history of or active infections, particularly fungal, bacterial, or viral infections. It may also be used cautiously in patients with liver impairment.
Drug Interaction
There are no significant drug interactions reported with Ciclesonide nasal spray due to its minimal systemic absorption. However, it is important to consider interactions with other nasal sprays or systemic corticosteroids.
Food Interactions
There are no known significant food interactions with Ciclesonide nasal spray.
Pregnancy Use
Ciclesonide is categorized as a Category C drug for pregnancy, meaning that risk cannot be ruled out. It should be used during pregnancy only if the benefits outweigh the risks and under the guidance of a healthcare provider.
Lactation Use
It is not known if Ciclesonide is excreted in breast milk. It should be used during lactation only if the benefits to the mother outweigh the potential risks to the infant. Consultation with a healthcare provider is recommended.
Acute Overdose
Acute overdose is unlikely with nasal administration, but excessive use can lead to systemic corticosteroid effects. In case of overdose, discontinuation of the drug and symptomatic treatment may be necessary.
Contraindication
Ciclesonide is contraindicated in patients with hypersensitivity to Ciclesonide or any component of the nasal spray. It should not be used in individuals with untreated fungal, bacterial, or viral infections of the nasal mucosa.
Use Direction
Follow the prescribed dosage and administration instructions. Do not exceed the recommended dose. Regular use is important for managing symptoms effectively. Consult with a healthcare provider if symptoms persist or worsen.
Storage Conditions
Store Ciclesonide nasal spray at room temperature, away from light and moisture. Do not freeze or store at high temperatures. Keep out of reach of children.
Volume of Distribution
The volume of distribution is minimal due to the localized action of the nasal spray and limited systemic absorption.
Half Life
The half-life of Ciclesonide is approximately 2-3 hours for the active metabolite, des-ciclesonide, following nasal administration.
Clearance
The clearance of Ciclesonide is low due to minimal systemic absorption, with most of the drug being metabolized in the liver and excreted in the urine.
